ECOBIOTICS IN ANTISOMA DEAL

A drug discovery company which scours north Queensland rainforests for compounds has signed a deal, potentially worth millions, with British cancer researchers. Publicly unlisted EcoBiotics described the deal to evaluate three compounds derived from rainforest plants as "significant" because it went to a focused anti-cancer drug developer in Antisoma.

The Herald Sun (http://www.heraldsun.news.com.au/common/story_page/0,5478,18393903%255E664,00.html)